semaglutide black box warning (Ozempic) carries FDA warnings for thyroid C-cell tumors based on rodent studies, with emerging human data showing higher thyroid cancer risk in early users. Over 2,900 lawsuits allege inadequate warnings for Semaglutide Safety Alerts, Recalls &

Research published in Cell Discovery examined the structural basis for retatrutide activating all three receptors, confirming that its molecular design allows potent simultaneous activation rather than weak partial agonism at any single receptor

Park JS, Kim KS, Choi HJ (2025) Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies

& Giroux, I

Brown explains

10.1007/s00726-011-1054-4 47

Newer research involving over 70,000 participants across 39 clinical trials paints a nuanced picture, one where certain types of clot risk may increase while overall cardiovascular outcomes actually improve